advertisement

Topcon

Schlötzer-Schrehardt U 3

Showing records 1 to 3 | Display all abstracts from Schlötzer-Schrehardt U

82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Hohberger B
Frontiers in immunology 2019; 10: 2112
82502 The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma
Schlötzer-Schrehardt U; Zenkel M
Experimental Eye Research 2019; 189: 107818
82654 Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Kunze R; Wallukat G; Kara K; Mardin CY; Lämmer R; Schlötzer-Schrehardt U; Hosari S; Hosari S; Horn F; Munoz L; Herrmann M
Frontiers in immunology 2019; 10: 2112

Issue 20-4

Change Issue


advertisement

Oculus